In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background: The emergence of Coronavirus disease (COVID-19) has been declared a pandemic and made a medical emergency worldwide. Various attempts have been made, including optimizing effective treatments against the disease or developing a vaccine. Since the SARS-CoV-2 protease crystal structure has been discovered, searching for its inhibitors by in silico technique becomes possible.
Objective: This study aims to virtually screen the potential of phytoconstituents from the Begonia genus as 3Cl pro-SARS-CoV- 2 inhibitors, based on its crucial role in viral replication, hence making these proteases “promising” for the anti-SARS-CoV-2 target.
Methods: In silico screening was carried out by molecular docking on the web-based program DockThor and validated by a retrospective method. Predictive binding affinity (Dock Score) was used for scoring the compounds. Further molecular dynamics on Desmond was performed to assess the complex stability.
Results: Virtual screening protocol was valid with the area under curve value 0.913. Molecular docking revealed only β-sitosterol-3-O-β-D-glucopyranoside with a lower docking score of - 9.712 kcal/mol than positive control of indinavir. The molecular dynamic study showed that the compound was stable for the first 30 ns simulations time with Root Mean Square Deviation <3 Å, despite minor fluctuations observed at the end of simulation times. Root Mean Square Fluctuation of catalytic sites HIS41 and CYS145 was 0.756 Å and 0.773 Å, respectively.
Conclusions: This result suggests that β-sitosterol-3-O-β-D- glucopyranoside might be a prospective metabolite compound that can be developed as anti-SARS-CoV-2.
CDC Weekly C, The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Wkly 2020;2:113–22. DOI: https://doi.org/10.46234/ccdcw2020.032
Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Bio Medica Atenei Parm 2020;91:157–60.
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533–4. DOI: https://doi.org/10.1016/S1473-3099(20)30120-1
Chen Y, Li L. SARS-CoV-2: virus dynamics and host response. Lancet Infect Dis. 2020;20:515–6. DOI: https://doi.org/10.1016/S1473-3099(20)30235-8
Echeverría-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco ME, et al. Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther 2021;19:147–63. DOI: https://doi.org/10.1080/14787210.2020.1813024
Satarker S, Ahuja T, Banerjee M, et al. Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2. Curr Pharmacol Rep 2020;6:203–11. DOI: https://doi.org/10.1007/s40495-020-00231-8
Chen J, Liu D, Liu L, et al. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Zhejiang Xue Xue Bao Yi Xue Ban J Zhejiang Univ Med Sci 2020;49:215–9.
Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;56:105949. DOI: https://doi.org/10.1016/j.ijantimicag.2020.105949
Farooq S, Ngaini Z. Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019). Chem Afr. 2021;4:1–13. DOI: https://doi.org/10.1007/s42250-020-00203-x
Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr Clin Res Rev. 2020 Jul;14(4):407–12. DOI: https://doi.org/10.1016/j.dsx.2020.04.020
Osipiuk J, Azizi SA, Dvorkin S, et al. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat Commun 2021;12:743. DOI: https://doi.org/10.1038/s41467-021-21060-3
Anirudhan V, Lee H, Cheng H, et al. Targeting SARS‐CoV‐2 viral proteases as a therapeutic strategy to treat COVID‐19. J Med Virol 2021;93:2722–34. DOI: https://doi.org/10.1002/jmv.26814
Siregar HM, Purwantoro R, Sudarmono FI, et al. Bio Pharmacy Potential of Begoniaceae (Begonia muricata Blume, B. multangu Blume, B. Baliensis Girmansyah) through In Vitro Antibacterial Test and Antifungal Test. In 2011.
Duke JA. Dr. Duke’s Phytochemical and Ethnobotanical Databases [Internet]. Ag Data Commons; 2016 [cited 2021 Nov 1]. Available from: https://data.nal.usda.gov/dataset/dr-dukes-phytochemical-and-ethnobotanical-databases
The Plant List. The Plant List A working list of all plant species [Internet]. 2010 [cited 2021 Oct 15]. Available from: http://www.theplantlist.org/browse/A/Begoniaceae/Begonia/
Kadir MF, Karmoker JR, Alam MdR, Jahan SR, Mahbub S, Mia MMK. Ethnopharmacological Survey of Medicinal Plants Used by Traditional Healers and Indigenous People in Chittagong Hill Tracts, Bangladesh, for the Treatment of Snakebite. Evid Based Complement Alternat Med 2015;2015:1–23. DOI: https://doi.org/10.1155/2015/871675
Rajbhandary S. Traditional Uses of Begonia Species (Begoniacae) in Nepal. J Nat Hist Mus 2015;27:25–34. DOI: https://doi.org/10.3126/jnhm.v27i0.14150
Girmansyah D. A taxonomic study of Bali and Lombok Begonia (Begoniaceae). Reinwardtia 2009;12:419–34.
Anam S, Yuliet, Ritna A, et al. Cytotoxic Activity of Benalu Batu (Begonia sp.) Methanolic Extract: An Ethnomedicine of Wana Tribe Central Sulawesi. J ILMU KEFARMASIAN Indones 2014;12.
Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283–91. DOI: https://doi.org/10.1107/S0021889892009944
Chen VB, Arendall WB, Headd JJ, et al. MolProbity : all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010;66:12–21. DOI: https://doi.org/10.1107/S0907444909042073
Zubair MS, Maulana S, Widodo A, et al. GC-MS, LC-MS/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-Chymotrypsin-like Protease Inhibitors from Zingiber officinale Roscoe. Molecules [Internet] 2021;26. DOI: https://doi.org/10.3390/molecules26175230
Irwin JJ, Shoichet BK, Mysinger MM, et al. Automated Docking Screens: A Feasibility Study. J Med Chem 2009;52:5712–20. DOI: https://doi.org/10.1021/jm9006966
Guedes IA, Costa LSC, dos Santos KB, et al. Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. Sci Rep 2021;11:5543. DOI: https://doi.org/10.1038/s41598-021-84700-0
Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004;3:935–49. DOI: https://doi.org/10.1038/nrd1549
Lengauer T, Rarey M. Computational methods for biomolecular docking. Curr Opin Struct Biol 1996;6:402–6. DOI: https://doi.org/10.1016/S0959-440X(96)80061-3
Triballeau N, Acher F, Brabet I, et al. Virtual Screening Workflow Development Guided by the “Receiver Operating Characteristic” Curve Approach. Application to High-Throughput Docking on Metabotropic Glutamate Receptor Subtype 4. J Med Chem 2005;48:2534–47. DOI: https://doi.org/10.1021/jm049092j
Hevener KE, Zhao W, Ball DM, et al. Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase. J Chem Inf Model 2009;49:444–60. DOI: https://doi.org/10.1021/ci800293n
Hubbard R, Haider M. Hydrogen Bonds in Proteins: Role and Strength. In: eLS 2010. DOI: https://doi.org/10.1002/9780470015902.a0003011.pub2
Koehl P, Delarue M. Polar and nonpolar atomic environments in the protein core: Implications for folding and binding. Proteins Struct Funct Genet 1994;20:264–78. DOI: https://doi.org/10.1002/prot.340200307
Duan G, Ji C, Zhang JZH. Developing an effective polarizable bond method for small molecules with application to optimized molecular docking. RSC Adv 2020;10:15530–40. DOI: https://doi.org/10.1039/D0RA01483D
Meller J. Molecular dynamics. Encycl Life Sci 2001;18. DOI: https://doi.org/10.1038/npg.els.0003048
Martínez L. Automatic Identification of Mobile and Rigid Substructures in Molecular Dynamics Simulations and Fractional Structural Fluctuation Analysis. Kleinjung J, editor. PLOS ONE 2015;10:e0119264. DOI: https://doi.org/10.1371/journal.pone.0119264
Yeni Y, Supandi S, Dwita L, et al. Docking studies and molecular dynamics simulation of Ipomoea batatas L. leaves compounds as lipoxygenase (LOX) inhibitor. J Pharm Bioallied Sci 2020;12:836. DOI: https://doi.org/10.4103/jpbs.JPBS_103_20
Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 2015;10:449–61. DOI: https://doi.org/10.1517/17460441.2015.1032936
Choudhary MI, Shaikh M, tul-Wahab A, ur-Rahman A. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. Salahub D, editor. PLOS ONE 2020;15:e0235030. DOI: https://doi.org/10.1371/journal.pone.0235030
Moonlight PW, Ardi WH, Padilla LA, et al. Dividing and conquering the fastest–growing genus: towards a natural sectional classification of the mega–diverse genus Begonia (Begoniaceae). Taxon 2018;67:267–323. DOI: https://doi.org/10.12705/672.3
Kiew R. A guide to begonias of Borneo. Kota Kinabalu: Natural History Publications (Borneo) 2015:293.
Ngazizah FN, Ekowati N, Septiana AT. Potensi daun trembilungan (Begonia hirtella Link) sebagai antibakteri dan antifungi. Maj Ilm Biol Biosf Sci J 2017;33:126–33. DOI: https://doi.org/10.20884/1.mib.2016.33.3.309
Siregar HM, Purwantoro RS, Praptiwi P, Agusta A. Antibacterial potency of simple fractions of ethyl acetate extract of Begonia baliensis. Nusant Biosci 2018;10:159–63. DOI: https://doi.org/10.13057/nusbiosci/n100305
Zubair MS, Alarif WM, Ghandourah MA, Anam S. A new steroid glycoside from Begonia sp. : cytotoxic activity and docking studies. Nat Prod Res 2019:1–8. DOI: https://doi.org/10.1080/14786419.2019.1669026
Zubair MS, Alarif WM, Ghandourah MA, et al. Cytotoxic Activity of 2-O-β-glucopyranosil Cucurbitacin D from Benalu Batu (Begonia sp.) Growing in Morowali, Central Sulawesi. Indones J Chem 2020;20:766. DOI: https://doi.org/10.22146/ijc.43626
Copyright (c) 2023 the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.